Ticker Launch

SPAC · Merger completed

GX Acquisition Corp.

Business combination with Celularity Inc.

GX Acquisition Corp. is a blank-check company (SPAC) that raised $250M in its initial public offering on May 21, 2019, listing on Nasdaq Capital Market. It completed its business combination with Celularity Inc. on Jul 16, 2021; the combined company is Celularity Inc. (CELU). Ellenoff Grossman & Schole advised the SPAC and Graubard Miller advised the underwriters on the IPO.

Celularity Inc. is a clinical-stage biotechnology company developing off-the-shelf, placenta-derived allogeneic cell therapies, including genetically modified NK cells, CAR T-cells and ASCs. They target indications across cancer, infectious diseases and degenerative diseases.

Status
Merger completed
IPO date
May 21, 2019
IPO size
$250M
IPO exchange
Nasdaq Capital Market
Target
Celularity Inc. (Legacy Celularity)
Announced
Jan 8, 2021
Closed
Jul 16, 2021
Combined company
Celularity Inc. (CELU)
SPAC counsel (IPO)
Ellenoff Grossman & Schole
Underwriters' counsel (IPO)
Graubard Miller

More on this SPAC for subscribers

Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.

Then $99/month or $999/year. Cancel anytime.

Filings

Other deSPACs that closed in 2021